16
Views
0
CrossRef citations to date
0
Altmetric
Original Article

Interleukin-2

Page 103 | Published online: 11 Jun 2009
 

Abstract

In major preclinical and clinical trials, Hoffman La-Roche is exploring the potential of interleukin-2 (IL-2) in the treatment of cancer. This lymphokine is being studied as a single agent and in combination with lymphokine-activated killer (LAK) cells.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.